Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ali Behbahani currently holds 93,568 shares of Black Diamond Therapeutics, Inc. (BDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ali Behbahani has been a net buyer of BDTX stock. They have purchased $203.5M and sold $993.8K worth of shares.
Ali Behbahani's most recent insider trade was on Mar 20, 2026, when they sold 6,919 shares at $2.15 per share.
Ali Behbahani serves as Executive at Black Diamond Therapeutics, Inc. (BDTX). They have executed 138 insider transactions totaling $204.5M over their tenure at the company.
Ali Behbahani holds the position of Executive at Black Diamond Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Ali Behbahani has shown a buying trading pattern, with $203.5M in total purchases and $993.8K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ali Behbahani was on Sep 16, 2024, when they purchased $8.0M worth of MBX shares. This transaction involved 500,000 shares at $16.00 per share.
Ali Behbahani currently owns 93,568 shares of Black Diamond Therapeutics, Inc. (BDTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ali Behbahani's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ali Behbahani has 138 Form 4 filings on record as an insider at Black Diamond Therapeutics, Inc..
Set alerts for Ali Behbahani and 40,000+ other insiders.